|03/06/14||The Medicines Company to Participate in 2014 Barclays Global Healthcare Conference|
|PARSIPPANY, NJ -- (Marketwired) -- 03/06/14 --
The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 2014 Barclays Global Healthcare Conference in Miami, FL on March 12th at 1:00 PM Eastern Time.
The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com.
About The Medicines Company
The Medicines Company's purpose is to save lives, alleviate suffering and contribute to the economics of healthcare by focus... |
|02/27/14||European Medicines Agency Accepts Marketing Authorization Application for The Medicines Company's Oritavancin|
|PARSIPPANY, NJ -- (Marketwired) -- 02/27/14 --
The Medicines Company (NASDAQ: MDCO) today announced that the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for the investigational intravenous antibiotic, oritavancin, for the treatment of complicated skin and skin tissue infections (cSSTI), caused by susceptible gram-positive bacteria, including by methicillin-resistant Staphylococcus aureus (MRSA), administered as a single dose.
The oritav... |
|02/19/14||The Medicines Company to Participate in Upcoming Healthcare Investor Conferences|
|PARSIPPANY, NJ -- (Marketwired) -- 02/19/14 --
The Medicines Company (NASDAQ: MDCO) is scheduled to present at the 2014 RBC Capital Markets' Global Healthcare Conference in New York on Tuesday, February 25th at 9:00 AM Eastern Time. Clive Meanwell, MD, PhD, Chairman and CEO, will participate in a question and answer format presentation. The session will be webcast with a link available at The Medicines Company's website http://www.themedicinescompany.com.
The Medicines Company will also be mee... |
|02/19/14||The Medicines Company Reports Fourth Quarter and Full Year 2013 Financial Results|
|Fourth Quarter Net Revenues Rise 16%; Full Year Net Revenues Rise 23%; Company Invests Aggressively in Acute and Intensive Care Portfolio and Anticipates for 6 New Product Launches in the Coming 2 Years
PARSIPPANY, NJ -- (Marketwired) -- 02/19/14 AMENDED 2/20/2014 -- The Medicines Company (NASDAQ: MDCO), a global company focused on saving lives, alleviating suffering, and improving the economic efficiency of the world's leading hospitals, today announced fourth quarter and full year financ... |